Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang